Parsons Capital Management Inc Acurx Pharmaceuticals, Inc. Transaction History
Parsons Capital Management Inc
- $1.58 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding ACXP
# of Institutions
37Shares Held
2.71MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$4.91 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$1.67 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$666,1380.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$662,1930.0% of portfolio
-
Morgan Stanley New York, NY106KShares$483,2140.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $52.6M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...